Accumetrics cordially invites you to an ACC.10 Industry-Expert Theater Presentation focusing on a rapidly evolving and exciting topic: assessing patient response to antiplatelet therapies and its impact on clinical outcomes. In joining the panel-based presentation and discussion, attendees will:
- Gain an understanding of the current and future landscape of oral antiplatelet therapy
- Review emerging data on the clinical utility of platelet assessment
- Gain insight into the impact of platelet reactivity on clinical outcomes via a comprehensive Meta−Analysis
Program Agenda
John Young, MD - Moderator
Director, Division of Cardiovascular Medicine & Medical Director, Heart Center
Adena Health System
Chief Medical Officer
Accumetrics Inc
Antiplatelet Therapy Landscape: 2010 and Beyond
Paul Gurbel, MD
Director of Cardiovascular Research
Sinai Hospital of Baltimore Inc
Assessing Response to Antiplatelet Therapy: What are the data telling us now?
Matthew J. Price, MD, FACC, FSCAI
Director, Cardiac Catheterization Laboratory
Scripps Clinic
Director, Interventional Cardiology Research
Scripps Genomic Medicine
Clinical Relevance of Point-of-Care Testing: A Meta-Analysis
Somjot S. Brar, MD
Director of Vascular Medicine & Staff Interventional Cardiologist
Kaiser Permanente
Sponsored by an educational grant from Accumetrics.
This event does not qualify for continuing medical education credit.
This event is not part of the official ACC Annual Scientific Session and/or the American College of Cardiology's Innovation in Intervention: i2 Summit in Partnership with the Cardiovascular Research Foundation (CRF) as planned by their Program Committees.